The ink on Friday's ASX 200 record high of 8566.9 is still drying as Australian stocks slumped today as fears and speculation ...

The S&P/ASX 200 Index logged its worst session since September 2024 after Trump announced sweeping tariffs on Canada, Mexico ...

Citi upgraded Zip to a Buy last Friday, citing strong US growth, new product potential and further earnings momentum.

Healthcare stocks are facing steep losses as several names have either manufacturing facilities in the tariffed countries and ...

A recap of the most heavily shorted stocks on the ASX and those experiencing significant changes to short interest over the ...

Welcome back to the Insider Trades Series – A weekly summary of on-market ASX director transactions valued at more than ...

Apple (-0.6%) 1Q25 EPS beat, with gross margins 40 bps above estimates, iPhone revenue missed by ~2%, Mac and iPad ...

PointsBet shares dipped 15% after the company cut its full-year revenue and earnings guidance. Here's what management had to ...

After the result, Barrenjoey upgraded their target price by 18% to $3.30.

ResMed (ASX: RMD) posted a solid December quarter, with most figures slightly exceeding market expectations, driven by strong ...

The S&P/ASX 200 is set to tick higher after a solid overnight session, which saw ten out of eleven S&P 500 sectors finish ...

These are the ASX companies and sectors making headlines in afternoon trade. Alterity Therapeutics (ASX: ATH) – Shares surged 100% after the clinical-stage biotech company announced positive results ...